Clinical Trial Update: Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²)

View source ↗

Summary

This document reports a completed clinical trial update for a cohort of non-small cell lung cancer patients with the CB(NPC)² mutation, sponsored by Centre Osca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Non-Small Cell Lung Cancer | Status: COMPLETED